Patient tumor tissue samples as well as ovarian cancer cell lines show relatively consistent protein levels regardless of ADRM1 mRNA expression levels suggesting that RPN13 expression is heavily post-transcriptionally regulated. This evidence concerns the gene ADRM1 and neoplasm.